Top Ten Questions: Understanding the Value and Benefits of AI-Based Plaque and Ischemia Analysis
Increasingly, cardiologists are turning to cardiac computed tomography angiogram (CCTA) as an accurate, non-invasive tool for diagnosing and guiding their treatment strategy for coronary artery disease. In this video series, learn about Cleerly, an AI-based CCTA analysis, and how this tool can enhance your workflow and diagnostic accuracy. Experts from across the fields of cardiology and diagnostic radiology answer your most frequently asked questions about clinical validation, real-world application and more.
CME credits are not offered for this educational program.
With Support From: ![cleerly-logomark-trnsprnt-535px-medium[83]](https://info.medaxiom.com/hs-fs/hubfs/cleerly-logomark-trnsprnt-535px-medium%5B83%5D.png?width=142&height=43&name=cleerly-logomark-trnsprnt-535px-medium%5B83%5D.png)
Submit your information to unlock this educational series.
Featured Speakers
Deepak L. Bhatt
MD, MPH, MBA, FACC, FAHA, FESC, MSCAI
Director, Mount Sinai Fuster Heart Hospital; Dr. Valentin Fuster Professor of Cardiovascular Medicine, Icahn School of Medicine, Mount Sinai
James Earls
MD, FSCCT
Chief Medical Officer, Cleerly; Professor of Radiology, George Washington University School of Medicine
Matthew Budoff
MD
Professor of Medicine, UCLA; Endowed Chair of Preventive Cardiology, Lundquist Institute
.png)
Andrew Choi
MD, FACC, MSCCT
Co-Director of Multimodality Cardiac Imaging and Associate Professor, George Washington University School of Medicine
Katharine L. Krol
MD, FSIR, FACR, RCCIR
Consultant; Past President, Society of Interventional Radiology; Member, Digital Medicine Payment Advisory Group, AMA